240 related articles for article (PubMed ID: 33476079)
1. IFNβ1 secreted by breast cancer cells undergoing chemotherapy reprograms stromal fibroblasts to support tumour growth after treatment.
Maia A; Gu Z; Koch A; Berdiel-Acer M; Will R; Schlesner M; Wiemann S
Mol Oncol; 2021 May; 15(5):1308-1329. PubMed ID: 33476079
[TBL] [Abstract][Full Text] [Related]
2. Inhibition of interferon-signalling halts cancer-associated fibroblast-dependent protection of breast cancer cells from chemotherapy.
Broad RV; Jones SJ; Teske MC; Wastall LM; Hanby AM; Thorne JL; Hughes TA
Br J Cancer; 2021 Mar; 124(6):1110-1120. PubMed ID: 33398063
[TBL] [Abstract][Full Text] [Related]
3. Chemotherapy induces the cancer-associated fibroblast phenotype, activating paracrine Hedgehog-GLI signalling in breast cancer cells.
Peiris-Pagès M; Sotgia F; Lisanti MP
Oncotarget; 2015 May; 6(13):10728-45. PubMed ID: 25915429
[TBL] [Abstract][Full Text] [Related]
4. Metabolic reprogramming of cancer-associated fibroblasts by TGF-β drives tumor growth: connecting TGF-β signaling with "Warburg-like" cancer metabolism and L-lactate production.
Guido C; Whitaker-Menezes D; Capparelli C; Balliet R; Lin Z; Pestell RG; Howell A; Aquila S; Andò S; Martinez-Outschoorn U; Sotgia F; Lisanti MP
Cell Cycle; 2012 Aug; 11(16):3019-35. PubMed ID: 22874531
[TBL] [Abstract][Full Text] [Related]
5. Autophagy in cancer associated fibroblasts promotes tumor cell survival: Role of hypoxia, HIF1 induction and NFκB activation in the tumor stromal microenvironment.
Martinez-Outschoorn UE; Trimmer C; Lin Z; Whitaker-Menezes D; Chiavarina B; Zhou J; Wang C; Pavlides S; Martinez-Cantarin MP; Capozza F; Witkiewicz AK; Flomenberg N; Howell A; Pestell RG; Caro J; Lisanti MP; Sotgia F
Cell Cycle; 2010 Sep; 9(17):3515-33. PubMed ID: 20855962
[TBL] [Abstract][Full Text] [Related]
6. Functions of paracrine PDGF signaling in the proangiogenic tumor stroma revealed by pharmacological targeting.
Pietras K; Pahler J; Bergers G; Hanahan D
PLoS Med; 2008 Jan; 5(1):e19. PubMed ID: 18232728
[TBL] [Abstract][Full Text] [Related]
7. Multiple changes induced by fibroblasts on breast cancer cells.
Cancemi P; Albanese NN; DiCara G; Marabeti MR; Costantini F; Minafra S; Pucci-Minafra I
Connect Tissue Res; 2010 Apr; 51(2):88-104. PubMed ID: 20001846
[TBL] [Abstract][Full Text] [Related]
8. Impact of stromal cell components of tumor microenvironment on epithelial-mesenchymal transition in breast cancer cells.
Bezdenezhnykh N; Semesiuk N; Lykhova O; Zhylchuk V; Kudryavets Y
Exp Oncol; 2014 Jun; 36(2):72-8. PubMed ID: 24980759
[TBL] [Abstract][Full Text] [Related]
9. Fibroblast-secreted hepatocyte growth factor mediates epidermal growth factor receptor tyrosine kinase inhibitor resistance in triple-negative breast cancers through paracrine activation of Met.
Mueller KL; Madden JM; Zoratti GL; Kuperwasser C; List K; Boerner JL
Breast Cancer Res; 2012 Jul; 14(4):R104. PubMed ID: 22788954
[TBL] [Abstract][Full Text] [Related]
10. Cancer-associated fibroblasts induce epithelial-mesenchymal transition of breast cancer cells through paracrine TGF-β signalling.
Yu Y; Xiao CH; Tan LD; Wang QS; Li XQ; Feng YM
Br J Cancer; 2014 Feb; 110(3):724-32. PubMed ID: 24335925
[TBL] [Abstract][Full Text] [Related]
11. Asporin is a stromally expressed marker associated with prostate cancer progression.
Rochette A; Boufaied N; Scarlata E; Hamel L; Brimo F; Whitaker HC; Ramos-Montoya A; Neal DE; Dragomir A; Aprikian A; Chevalier S; Thomson AA
Br J Cancer; 2017 Mar; 116(6):775-784. PubMed ID: 28152543
[TBL] [Abstract][Full Text] [Related]
12. TGF-beta receptor type-2 expression in cancer-associated fibroblasts regulates breast cancer cell growth and survival and is a prognostic marker in pre-menopausal breast cancer.
Busch S; Acar A; Magnusson Y; Gregersson P; Rydén L; Landberg G
Oncogene; 2015 Jan; 34(1):27-38. PubMed ID: 24336330
[TBL] [Abstract][Full Text] [Related]
13. Cancer/stroma interplay via cyclooxygenase-2 and indoleamine 2,3-dioxygenase promotes breast cancer progression.
Chen JY; Li CF; Kuo CC; Tsai KK; Hou MF; Hung WC
Breast Cancer Res; 2014 Jul; 16(4):410. PubMed ID: 25060643
[TBL] [Abstract][Full Text] [Related]
14. Breast cancer-associated fibroblasts induce epithelial-to-mesenchymal transition in breast cancer cells.
Soon PS; Kim E; Pon CK; Gill AJ; Moore K; Spillane AJ; Benn DE; Baxter RC
Endocr Relat Cancer; 2013 Feb; 20(1):1-12. PubMed ID: 23111755
[TBL] [Abstract][Full Text] [Related]
15. Aberrant low expression of p85α in stromal fibroblasts promotes breast cancer cell metastasis through exosome-mediated paracrine Wnt10b.
Chen Y; Zeng C; Zhan Y; Wang H; Jiang X; Li W
Oncogene; 2017 Aug; 36(33):4692-4705. PubMed ID: 28394344
[TBL] [Abstract][Full Text] [Related]
16. Lactate is a mediator of metabolic cooperation between stromal carcinoma associated fibroblasts and glycolytic tumor cells in the tumor microenvironment.
Rattigan YI; Patel BB; Ackerstaff E; Sukenick G; Koutcher JA; Glod JW; Banerjee D
Exp Cell Res; 2012 Feb; 318(4):326-35. PubMed ID: 22178238
[TBL] [Abstract][Full Text] [Related]
17. Primary breast myoepithelial cells exert an invasion-suppressor effect on breast cancer cells via paracrine down-regulation of MMP expression in fibroblasts and tumour cells.
Jones JL; Shaw JA; Pringle JH; Walker RA
J Pathol; 2003 Dec; 201(4):562-72. PubMed ID: 14648659
[TBL] [Abstract][Full Text] [Related]
18. Paracrine TGF-β1 from breast cancer contributes to chemoresistance in cancer associated fibroblasts via upregulation of the p44/42 MAPK signaling pathway.
Chandra Jena B; Kanta Das C; Banerjee I; Das S; Bharadwaj D; Majumder R; Mandal M
Biochem Pharmacol; 2021 Apr; 186():114474. PubMed ID: 33607074
[TBL] [Abstract][Full Text] [Related]
19. Breast stromal fibroblasts from histologically normal surgical margins are pro-carcinogenic.
Al-Rakan MA; Colak D; Hendrayani SF; Al-Bakheet A; Al-Mohanna FH; Kaya N; Al-Malik O; Aboussekhra A
J Pathol; 2013 Dec; 231(4):457-65. PubMed ID: 24009142
[TBL] [Abstract][Full Text] [Related]
20. CHEK2 represses breast stromal fibroblasts and their paracrine tumor-promoting effects through suppressing SDF-1 and IL-6.
Al-Rakan MA; Hendrayani SF; Aboussekhra A
BMC Cancer; 2016 Aug; 16():575. PubMed ID: 27484185
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
